Published in Am J Cardiol on April 01, 1989
Transcatheter occlusion of the patent ductus arteriosus with Cook detachable coils. Heart (1996) 1.91
Transcatheter closure of patent ductus arteriosus with severe pulmonary arterial hypertension in adults. Heart (2006) 1.53
Transcatheter closure of large patent ductus arteriosus (> or = 4 mm) with multiple Gianturco coils: immediate and mid-term results. Heart (1996) 1.47
Transcatheter closure of high pulmonary artery pressure persistent ductus arteriosus with the Amplatzer muscular ventricular septal defect occluder. Heart (2002) 1.33
Total UK multi-centre experience with a novel arterial occlusion device (Duct Occlud pfm). Heart (1996) 1.22
Stenting the ductus arteriosus: Case selection, technique and possible complications. Ann Pediatr Cardiol (2008) 1.15
Transcatheter closure of persistent ductus arteriosus in infants using the Amplatzer duct occluder. Heart (2001) 1.14
The results of transcatheter occlusion of patent ductus arteriosus: success rate and complications over 12 years in a single center. Korean Circ J (2010) 1.09
Transcatheter closure of patent ductus arteriosus using ado device: retrospective study of 149 patients. Heart Views (2012) 1.09
Complications after transcatheter closure of patent ductus arteriosus. J Korean Med Sci (2007) 1.05
Miniinvasive hybrid procedure for device migration after percutaneous closure of persistent arterial duct: a case report. Wideochir Inne Tech Maloinwazyjne (2012) 1.01
Transcatheter closure of patent ductus arteriosus and interruption of inferior vena cava with azygous continuation using an Amplatzer duct occluder II. Ann Pediatr Cardiol (2009) 0.99
Transcatheter closure of patent ductus arteriosus and interruption of inferior vena cava with azygous continuation using an Amplatzer duct occluder. Pediatr Cardiol (2006) 0.96
Percutaneous closure of window-type patent ductus arteriosus: using the CardioSEAL and STARFlex devices. Tex Heart Inst J (2003) 0.96
Safety and efficacy of transcatheter closure of large patent ductus arteriosus in adults with a self-expandable occluder. Heart Vessels (2009) 0.94
Rescrewing the embolized duct occluder using the delivery cable. Ann Pediatr Cardiol (2014) 0.91
Patent arterial duct. Orphanet J Rare Dis (2009) 0.88
Transcatheter closure of patent ductus arteriosus: Evaluating the effect of the learning curve on the outcome. Ann Pediatr Cardiol (2009) 0.88
Lung perfusion studies after detachable coil occlusion of persistent arterial duct. Heart (1999) 0.87
Transcatheter closure of a large patent ductus arteriosus in a young child using the Amplatzer duct occluder. Pediatr Cardiol (2005) 0.86
Recent strategies and outcomes of transcatheter closure for patent ductus arteriosus. Korean Circ J (2010) 0.85
Comparison of the efficacy of different-sized Amplatzer duct occluders (I, II, and II AS) in children weighing less than 10 kg. Pediatr Cardiol (2012) 0.85
Thoracoscopic ligation versus coil occlusion for patent ductus arteriosus: a matched cohort study of outcomes and cost. Surg Endosc (2007) 0.84
Factors influencing the persistence of shunting within 24 hours of catheter occlusion of the ductus arteriosus. Br Heart J (1991) 0.84
Visualization of patent ductus arteriosus using real-time three-dimensional echocardiogram: Comparative study with 2D echocardiogram and angiography. J Saudi Heart Assoc (2012) 0.83
Percutaneous closure of a moderate to large tubular or elongated patent ductus arteriosus in children younger than 3 years: is the ADO II appropriate? Pediatr Cardiol (2013) 0.82
Embolization of Gianturco coil into the pulmonary artery requiring emergency surgical intervention. Tex Heart Inst J (1999) 0.81
Transthoracic echocardiography as an alternative major guidance to angiography during transcatheter closure of patent ductus arteriosus: technical feasibility and clinical relevance. Pediatr Cardiol (2014) 0.80
Percutaneous Patent Ductus Arteriosus (PDA) Closure in Very Preterm Infants: Feasibility and Complications. J Am Heart Assoc (2016) 0.79
Usefulness of Doppler derived end diastolic flow gradient across the patent ductus arteriosus in selecting coils for ductal occlusion. Pediatr Cardiol (2011) 0.79
Transcatheter closure of PDA in premature babies less than 2 kg. Anatol J Cardiol (2016) 0.78
Multiple thromboembolism with multiple causes in a 69-year-old woman: a case report. J Med Case Rep (2011) 0.78
Transcatheter closure of small ductus arteriosus with amplatzer vascular plug. Korean J Pediatr (2013) 0.78
Transcatheter closure of patent ductus arteriosus among native high-altitude habitants. Pediatr Cardiol (2007) 0.77
Illustrated Imaging Essay on Congenital Heart Diseases: Multimodality Approach Part II: Acyanotic Congenital Heart Disease and Extracardiac Abnormalities. J Clin Diagn Res (2016) 0.77
Transcatheter closure of patent ductus arteriosus in children weighing 10 kg or less: Initial experience at Sohag University Hospital. J Saudi Heart Assoc (2015) 0.77
Update on the Amplatzer duct occluder: a 10-year experience in Asia. Pediatr Cardiol (2011) 0.77
Inadvertent ligation of the left pulmonary artery during intended ductal ligation. BMC Res Notes (2015) 0.75
Coil occlusion of the large patent ductus arteriosus. Images Paediatr Cardiol (2008) 0.75
Spring coil retraction in coil occlusion of persistent ductus arteriosus. Heart (1998) 0.75
Single catheter approach for occlusion of a patent arterial duct with a Rashkind double umbrella. Br Heart J (1995) 0.75
Transcatheter closure of patent ductus arteriosus: 11 years of clinical experience in Cipto Mangunkusumo Hospital, Jakarta, Indonesia. Pediatr Cardiol (2015) 0.75
Comparative study between real time three dimensional echocardiogram and angiography in evaluation of patent ductus arteriosus, single center experience. J Saudi Heart Assoc (2014) 0.75
Amplatzer Device closure of Atrial Septal Defects and Patent Ductus Arteriosus: Initial Experience. Med J Armed Forces India (2011) 0.75
Techniques in Cardiology : PDA Closure in Children. Med J Armed Forces India (2011) 0.75
Morphology of the patent arterial duct: features relevant to treatment. Images Paediatr Cardiol (2008) 0.75
Patent ductus arteriosus closure using an Amplatzer(™) ventricular septal defect closure device. Exp Clin Cardiol (2013) 0.75
Follow-Up Results of Device Occlusion of Patent Ductus Arteriosus. Iran J Pediatr (2016) 0.75
Ductal closure using the Amplatzer duct occluder type two: experience in Port Elizabeth hospital complex, South Africa: cardiovascular topic. Cardiovasc J Afr (2013) 0.75
Percutaneous closure of patent arterial ducts in patients from high altitude: a sub-Saharan experience. Ann Pediatr Cardiol (2015) 0.75
Novel kissing catheter technique for foreign body retrieval. Ann Pediatr Cardiol (2014) 0.75
A Retrospective Study of 1,526 Cases of Transcatheter Occlusion of Patent Ductus Arteriosus. Chin Med J (Engl) (2015) 0.75
Multicenter Off-Label Use of Nit-Occlud Coil in Retrograde Closure of Small Patent Ductus Arteriosus. Pediatr Cardiol (2017) 0.75
Type B patent ductus arteriosus. Pediatr Cardiol (2007) 0.75
Transcatheter closure of symptomatic arterial duct in infants younger than 1 year old. Pediatr Cardiol (2012) 0.75
Initial experience with the 3.3 Fr Mongoose(®) pigtail catheter for aortic angiography during patent ductus arteriosus closure in small patients. Ann Pediatr Cardiol (2017) 0.75
Interventional Closure of a Patent Ductus Arteriosus Using an Amplatz Canine Duct Occluder in an Alpaca Cria. J Vet Intern Med (2017) 0.75
Echocardiographic Versus Angiographic Assessment of Patent Arterial Duct in Percutaneous Closure: Towards X-ray Free Duct Occlusion? Pediatr Cardiol (2017) 0.75
Novel procedure for treatment of aortic obstruction caused by amplatzer occluder of patent ductus arteriosus. Pediatr Cardiol (2008) 0.75
Patent ductus arteriosus aneurysm: a rare cause of dyspnea in an adolescent boy. Pediatr Cardiol (2012) 0.75
Transcatheter occlusion of the persistently patent ductus arteriosus. Forty-month follow-up and prevalence of residual shunting. Circulation (1991) 3.90
ESHAP--an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study. J Clin Oncol (1994) 3.22
Aortic dissection after stent dilatation for coarctation of the aorta: a case report and literature review. Catheter Cardiovasc Interv (2003) 2.82
Evidence that murine pre-B cells synthesise mu heavy chains but no light chains. Nature (1979) 2.74
Association of serum Rituximab (IDEC-C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin's lymphoma. Ann Oncol (1998) 2.57
Natural history of cardiac rhabdomyoma in infancy and childhood. Am J Cardiol (1990) 2.46
Pediatric primary benign cardiac tumors: a 15-year review. Am Heart J (1997) 2.43
Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin's lymphoma: safety and efficacy of re-treatment. J Clin Oncol (2000) 2.38
Portacaval shunt in patients with familial hypercholesterolemia. Ann Surg (1983) 2.33
Complications associated with pediatric cardiac catheterization. J Am Coll Cardiol (1998) 2.32
Outcomes in patients with pulmonary hypertension undergoing percutaneous atrial septal defect closure. Heart (2007) 2.30
Sequential segmental analysis of congenital heart disease. Pediatr Cardiol (1984) 2.12
Pulmonary valve replacement late after repair of tetralogy of Fallot. Ann Thorac Surg (1997) 2.08
Significance of tumor size and radiation dose to local control in stage I-III diffuse large cell lymphoma treated with CHOP-Bleo and radiation. Int J Radiat Oncol Biol Phys (1995) 2.05
Outcome of coronary artery aneurysms after Kawasaki disease. J Pediatr (1992) 2.03
ABO-incompatible heart transplantation in infants. N Engl J Med (2001) 2.01
Stenting of the right ventricular outflow tract in the symptomatic infant with tetralogy of Fallot. Heart (2008) 1.99
Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP). Blood (1988) 1.95
Long-term outcome and prognostic determinants in children with hypertrophic cardiomyopathy. J Am Coll Cardiol (1998) 1.92
Doppler echocardiographic measurement of pulmonary artery pressure from ductal Doppler velocities in the newborn. J Am Coll Cardiol (1990) 1.91
Scimitar syndrome: twenty years' experience and results of repair. J Thorac Cardiovasc Surg (1996) 1.90
Arrhythmia and mortality after the Mustard procedure: a 30-year single-center experience. J Am Coll Cardiol (1997) 1.88
Myocardial bridging in children with hypertrophic cardiomyopathy--a risk factor for sudden death. N Engl J Med (1998) 1.82
Developmental venous anomalies (DVA): the so-called venous angioma. Neurosurg Rev (1986) 1.80
The modified Blalock-Taussig shunt: clinical impact and morbidity in Fallot's tetralogy in the current era. J Thorac Cardiovasc Surg (1997) 1.78
Ultrasound diagnosis of fibroadenoma - is biopsy always necessary? Clin Radiol (2008) 1.78
Dilated cardiomyopathy with neutropenia, short stature, and abnormal carnitine metabolism. J Pediatr (1988) 1.76
Abnormal position of the brachiocephalic vein. Am J Cardiol (1985) 1.71
Spectrum of cardiovascular anomalies in Williams-Beuren syndrome. Pediatr Cardiol (1991) 1.68
Evolving strategies and improving outcomes of the modified norwood procedure: a 10-year single-institution experience. Ann Thorac Surg (2001) 1.67
Iliofemoral arterial complications of balloon angioplasty for systemic obstructions in infants and children. Circulation (1990) 1.65
Analysis of survival in patients with pulmonic valve atresia and ventricular septal defect. Am J Cardiol (1991) 1.63
Independent factors associated with longevity of prosthetic pulmonary valves and valved conduits. J Thorac Cardiovasc Surg (2000) 1.62
Repair of coarctation of the aorta in children: postoperative morphology. Radiology (1991) 1.58
Congenital cardiovascular disease and anomalies of the third and fourth pharyngeal pouch. Circulation (1972) 1.57
Morphologic and hemodynamic consequences after percutaneous balloon valvotomy for neonatal pulmonary stenosis: medium-term follow-up. J Am Coll Cardiol (1996) 1.57
Cardiac rhabdomyomas and obstructive left heart disease: histologically but not functionally benign. Ann Thorac Surg (1998) 1.54
Outcome in cyanotic neonates with Ebstein's anomaly. Am J Cardiol (1998) 1.54
Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma. Blood (1998) 1.54
Scimitar syndrome in infancy. J Am Coll Cardiol (1993) 1.52
Endovascular stents in the pulmonary circulation. Clinical impact on management and medium-term follow-up. Circulation (1995) 1.52
Repair of isolated multiple muscular ventricular septal defects: the septal obliteration technique. Ann Thorac Surg (2000) 1.51
Transcatheter perforation of the right ventricular outflow tract as initial therapy for pulmonary valve atresia and intact ventricular septum in the newborn. Cathet Cardiovasc Diagn (1997) 1.49
Pre-closure of femoral venous access sites used for large-sized sheath insertion with the Perclose device in adults undergoing cardiac intervention. Heart (2006) 1.49
Subaortic stenosis in the spectrum of atrioventricular septal defects. Solutions may be complex and palliative. J Thorac Cardiovasc Surg (1995) 1.49
What is the optimal age for repair of tetralogy of Fallot? Circulation (2000) 1.47
Minimally invasive repair of atrial septal defects. Ann Thorac Surg (1998) 1.47
Percutaneous pericardial catheter drainage in childhood. Am J Cardiol (1992) 1.45
Truncal valve repair: initial experience in neonates. Ann Thorac Surg (1998) 1.45
Pial arteriovenous fistula in children as presenting manifestation of Rendu-Osler-Weber disease. Neuroradiology (1995) 1.43
Regional ventricular wall motion abnormalities in tricuspid atresia after the Fontan procedure. J Am Coll Cardiol (1993) 1.42
Outcomes in neonatal pulmonary atresia with intact ventricular septum. A multiinstitutional study. J Thorac Cardiovasc Surg (1993) 1.42
A case-control study assessing bone mineral density in severe haemophilia A in the UK. Haemophilia (2014) 1.41
Stenting of coronary artery stenosis in Kawasaki disease. Catheter Cardiovasc Interv (1999) 1.41
Replacement of routine liver biopsy by procollagen III aminopeptide for monitoring patients with psoriasis receiving long-term methotrexate: a multicentre audit and health economic analysis. Br J Dermatol (2005) 1.40
Complete atrioventricular septal defects: results of repair, risk factors, and freedom from reoperation. Circulation (1997) 1.40
Subaortic stenosis, the univentricular heart, and banding of the pulmonary artery: an analysis of the courses of 43 patients with univentricular heart palliated by pulmonary artery banding. Circulation (1986) 1.40
Anomalous origin of one pulmonary artery from the ascending aorta: 36 years' experience from one centre. Cardiol Young (1998) 1.40
Right-to-left shunt following repair of partial anomalous pulmonary venous connection: a novel use of the Rashkind double-umbrella occlusion device. Cathet Cardiovasc Diagn (1994) 1.39
Multiple cerebral arteriovenous malformations (AVMs). Review of our experience from 203 patients with cerebral vascular lesions. Neuroradiology (1990) 1.38
Congenital aortico-right atrial communications. The dilemma of differentiation from coronary-cameral fistula. J Thorac Cardiovasc Surg (1986) 1.38
Catheter occlusion of the persistently patent ductus arteriosus. Am J Cardiol (1988) 1.38
Neonatal aortic stenosis. The balloon deflated? J Thorac Cardiovasc Surg (1990) 1.38
Assessing clinical competence and revalidation of clinicians. Simulated surgeries would have advantages. BMJ (2001) 1.38
Validation of Doppler-derived pulmonary arterial pressure in patients with ductus arteriosus under different hemodynamic states. Circulation (1987) 1.36
Endovascular stents in the management of coarctation of the aorta in the adolescent and adult: one year follow up. Heart (2001) 1.35
Two-dimensional echocardiographic and color flow Doppler evaluation of ductal occlusion with the Rashkind prosthesis. Circulation (1989) 1.34
The criss-cross and superoinferior ventricular heart: an angiocardiographic study. Am J Cardiol (1978) 1.34
An echocardiographic study of the association of ventricular septal defect and right ventricular muscle bundles with a fixed subaortic abnormality. Am J Cardiol (1988) 1.33
Intravascular stent prosthesis for right ventricular outflow obstruction. J Am Coll Cardiol (1992) 1.33
Echocardiographic follow-up of atrial septal defect after catheter closure by double-umbrella device. Circulation (1993) 1.33
The asplenia syndrome: a review of significant extracardiac structural abnormalities in 29 necropsied patients. J Pediatr (1972) 1.31
Extracardiac conduit versus lateral tunnel cavopulmonary connections at a single institution: impact on outcomes. J Thorac Cardiovasc Surg (2001) 1.31
Risk factors for atrial tachyarrhythmias after the Fontan operation. J Am Coll Cardiol (1994) 1.29
Tissue plasminogen activator for the treatment of thromboembolism in infants and children. J Pediatr (1991) 1.26
Late results following repair of partial anomalous pulmonary venous connection with sinus venosus atrial septal defect. J Thorac Cardiovasc Surg (1980) 1.26
Thrombolytic therapy for femoral artery thrombosis after pediatric cardiac catheterization. Am Heart J (1988) 1.25
Impact of dynamic 3D transoesophageal echocardiography in the assessment of atrial septal defects and occlusion by the double-umbrella device (CardioSEAL) Cardiol Young (1998) 1.22
Safety and outcomes of thrombolysis with tissue plasminogen activator for treatment of intravascular thrombosis in children. J Pediatr (2001) 1.20
Richter's syndrome: a report on 39 patients. J Clin Oncol (1993) 1.19